GlassScriptPhysician profile
David M Stella
NPI 1992724298
$349.16
in general payments reported to CMS, 2019-2025
8 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.95 · 2023: $93.42 · 2024: $17.48 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $92.21 | 2023-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Envista Envy Iol |
| Dompe US, INC. | $71.22 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $60.15 | 2025 | |
| Abbvie INC. | $30.49 | 2025 | |
| Alcon Vision LLC | $29.09 | 2025 | Tryptyr |
| Tarsus Pharmaceuticals, INC. | $27.71 | 2025 | Xdemvy |
| Glaukos Corporation | $20.81 | 2023 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Sight Sciences, INC. | $17.48 | 2024 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.